MYCN and neuroblastoma: Three different neuroblastoma cell lines of ADRN MYCN-amplified, ADRN MYCN non-amplified, and MES subtype cells were treated with all-trans-retinoic acid (ATRA) and the super-enhancer landscape after treatment and upon subsequent removal of retinoic acid was studied.